Related Experiment Video
Updated: May 27, 2026

07:10
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
Cross-reactions vs co-sensitization evaluated by in silico motifs and in vitro IgE microarray testing
P Pfiffner1, B M Stadler, C Rasi
1University Institute of Immunology, University of Bern, Switzerland.
Allergy
|November 8, 2011
Summary
Most allergen co-reactions are true cross-reactions, not co-sensitizations, with a hierarchy observed based on allergen frequency in allergic individuals. This finding impacts future allergic disease management.
Area of Science:
- Immunology
- Bioinformatics
- Allergy Research
Background:
- Recent in silico studies demonstrated high cross-reactivity in allergen extracts.
- Allergens share sequence motifs, suggesting potential for cross-reactions.
Purpose of the Study:
- To differentiate true cross-reactions from co-sensitizations using serological data.
- To investigate the role of shared sequence motifs in allergen cross-reactivity.
Main Methods:
- Analysis of serological data from 3142 samples tested against 103 allergens using a multi-array IgE test.
- Application of an iterative motif-finding algorithm to predict cross-reactivity based on sequence motifs.
Main Results:
- Allergen proteins with shared motifs exhibited cross-reactivity as predicted.
- A hierarchy of cross-reactivity was observed, inversely related to allergen frequency.
- Most observed co-reactions were confirmed as cross-reactions, not co-sensitizations.
Conclusions:
- The hierarchy of allergen cross-reactivity is a significant factor in allergic disease.
- Findings suggest implications for the clinical management of allergies.
Related Concept Videos
Cross-reactivity
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions
Overview
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

